Erratum to: A dysfunctional tricarboxylic acid cycle enhances fitness of Staphylococcus epidermidis during β-lactam stress (4, 4, (2013), doi:10.1128/mBio.00437-13);A dysfunctional tricarboxylic acid cycle enhances fitness of Staphylococcus epidermidis during β-lactam stress

mBio

Volumn 4, Issue 4, 2013, Pages 1-

  Chittezham Thomas, Vinai ^a   Kinkead, Lauren C ^a   Janssen, Ashley ^a   Schaeffer, Carolyn R ^a   Woods, Keith M ^a   Lindgren, Jill K ^a   Peaster, Jonathan M ^a   Chaudhari, Sujata S ^a   Sadykov, Marat ^a   Jones, Joselyn ^b   Mohamadi AbdelGhani, Sameh M ^c   Zimmerman, Matthew C ^b   Bayles, Kenneth W ^a   Somerville, Greg A ^d   Fey, Paul D ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c BENI SUEF UNIVERSITY   (Egypt)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DAPTOMYCIN; OXACILLIN; REACTIVE OXYGEN METABOLITE; RIFAMPICIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLYSIS; BACTERIAL CELL; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BACTERIUM MUTANT; CELL DEATH; CELL SURFACE; CITRIC ACID CYCLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETOXIFICATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84883310846     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01307-14     Document Type: Erratum

References (23)

1. Somerville GA, Proctor RA. 2009. At the crossroads of bacterial metabolism and virulence factor synthesis in staphylococci. Microbiol. Mol. Biol. Rev. 73:233-248.
2. Sadykov MR, Zhang B, Halouska S, Nelson JL, Kreimer LW, Zhu Y, Powers R, Somerville GA. 2010. Using NMR metabolomics to investigate tricarboxylic acid cycle-dependent signal transduction in Staphylococcus epidermidis. J. Biol. Chem. 285:36616-36624.
3. Goswami M, Mangoli SH, Jawali N. 2006. Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob. Agents Chemother. 50:949-954.
4. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810.
5. Liu Y, Liu X, Qu Y, Wang X, Li L, Zhao X. 2012. Inhibitors of reactive oxygen species accumulation delay and/or reduce the lethality of several antistaphylococcal agents. Antimicrob. Agents Chemother. 56: 6048-6050.
6. Keren I, Wu Y, Inocencio J, Mulcahy LR, Lewis K. 2013. Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339:1213-1216.
7. Liu Y, Imlay JA. 2013. Cell death from antibiotics without the involvement of reactive oxygen species. Science 339:1210-1213.
8. Fang FC. 2013. Antibiotic and ROS linkage questioned. Nat. Biotechnol. 31:415-416.
9. Sadykov MR, Olson ME, Halouska S, Zhu Y, Fey PD, Powers R, Somerville GA. 2008. Tricarboxylic acid cycle-dependent regulation of Staphylococcus epidermidis polysaccharide intercellular adhesin synthesis. J. Bacteriol. 190:7621-7632.
10. Lambert RJ, Pearson J. 2000. Susceptibility testing: accurate and reproducible minimum inhibitory concentration (MIC) and non-inhibitory concentration (NIC) values. J. Appl. Microbiol. 88:784-790.
11. Schaad HJ, Bento M, Lew DP, Vaudaux P. 2006. Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection. BMC Infect. Dis. 6:74.
12. Cole M, Kenig MD, Hewitt VA. 1973. Metabolism of penicillins to penicilloic acids and 6-aminopenicillanic acid in man and its significance in assessing penicillin absorption. Antimicrob. Agents Chemother. 3:463-468.
13. Rosenblatt JE, Kind AC, Brodie JL, Kirby WM. 1968. Mechanisms responsible for the blood level differences of isoxazolyl penicillins: oxacillin, cloxacillin, and dicloxacillin. Arch. Intern. Med. 121:345-348.
14. Kohanski MA, Dwyer DJ, Collins JJ. 2010. How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol. 8:423-435.
15. Frawley ER, Crouch ML, Bingham-Ramos LK, Robbins HF, Wang W, Wright GD, Fang FC. 2013. Iron and citrate export by a major facilitator superfamily pump regulates metabolism and stress resistance in Salmonella Typhimurium. Proc. Natl. Acad. Sci. U. S. A. 110:12054-12059.
16. Mailloux RJ, Bériault R, Lemire J, Singh R, Chénier DR, Hamel RD, Appanna VD. 2007. The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS One 2:. dOI: 10.1371/ journal.pone.0000690e690.
17. Helmann JD. 2011. Bacillithiol, a new player in bacterial redox homeostasis. Antioxid. Redox Signal. 15:123-133.
18. Gaballa A, Newton GL, Antelmann H, Parsonage D, Upton H, Rawat M, Claiborne A, Fahey RC, Helmann JD. 2010. Biosynthesis and functions of bacillithiol, a major low-molecular-weight thiol in bacilli. Proc. Natl. Acad. Sci. U. S. A. 107:6482-6486.
19. Best GK, Best NH, Koval AV. 1974. Evidence for participation of autolysins in bactericidal action of oxacillin on Staphylococcus aureus. Antimicrob. Agents Chemother. 6:825-830.
20. Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, DeLeo FR, Otto M. 2004. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J. Biol. Chem. 279: 54881-54886.
21. Zoll S, Pätzold B, Schlag M, Götz F, Kalbacher H, Stehle T. 2010. Structural basis of cell wall cleavage by a staphylococcal autolysin. PLOS Pathog. 6:e1000807. doi: 10.1371/journal.ppat.1000807.
22. Zoll S, Schlag M, Shkumatov AV, Rautenberg M, Svergun DI, Götz F, Stehle T. 2012. Ligand-binding properties and conformational dynamics of autolysin repeat domains in staphylococcal cell wall recognition. J. Bacteriol. 194:3789-3802.
23. Yang SJ, Nast CC, Mishra NN, Yeaman MR, Fey PD, Bayer AS. 2010. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms. Antimicrob. Agents Chemother. 54: 3079-3085.